↓ Skip to main content

Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies

Overview of attention for article published in Annals of Hematology, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
27 Mendeley
Title
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
Published in
Annals of Hematology, January 2019
DOI 10.1007/s00277-018-3585-1
Pubmed ID
Authors

Yu-Lin Zhang, Yan Zhu, Qing Xiao, Li Wang, Lin Liu, Xiao-Hua Luo

Abstract

Cytomegalovirus (CMV) infection and primary disease relapse remain challenging problems after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We sought to assess the association between CMV infection and disease relapse after transplantation. PubMed, EMBASE, the Cochrane Library, SCI, and Chinese Biomedicine Databases were searched up to July 1, 2018, for all studies that investigate pre-transplant CMV serostatus, CMV replication, and primary disease relapse in allo-HSCT patients with hematologic malignancies. Meta-analysis of 24 eligible cohort studies showed a significantly lower relapse risk after allo-HSCT in patients with CMV replication in acute myeloid leukemia (AML) (HR = 0.64, 95% CI, 0.50-0.83; P < 0.001) subgroup. However, CMV replication was associated with increased non-relapse mortality (NRM) in AML patients (HR = 1.64, 95% CI, 1.46-1.85; P < 0.001), but not associated with overall survival (OS) or graft-versus-host disease for AML patients (P > 0.05). There was no association between pre-transplant CMV serostatus and disease relapse, although D-/R- was associated with better OS in acute leukemia patients (HR = 0.89, 95% CI, 0.83-0.96; P = 0.003). In AML patients, CMV replication may be a protective predictor against disease relapse, although the potential benefit of CMV replication is offset by increased NRM.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 19%
Researcher 5 19%
Student > Doctoral Student 4 15%
Student > Master 3 11%
Student > Bachelor 1 4%
Other 2 7%
Unknown 7 26%
Readers by discipline Count As %
Medicine and Dentistry 12 44%
Business, Management and Accounting 1 4%
Nursing and Health Professions 1 4%
Immunology and Microbiology 1 4%
Computer Science 1 4%
Other 2 7%
Unknown 9 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2019.
All research outputs
#8,400,787
of 25,713,737 outputs
Outputs from Annals of Hematology
#514
of 2,434 outputs
Outputs of similar age
#163,045
of 449,461 outputs
Outputs of similar age from Annals of Hematology
#16
of 50 outputs
Altmetric has tracked 25,713,737 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,434 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,461 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.